发明名称 |
COMPOSITIONS, KITS, AND METHODS FOR THE DIAGNOSIS, PROGNOSIS, MONITORING, TREATMENT AND MODULATION OF POST-TRANSPLANT LYMPHOPROLIFERATIVE DISORDERS AND HYPOXIA ASSOCIATED ANGIOGENESIS DISORDERS USING GALECTIN-1 |
摘要 |
<p>The present invention is based, in part, on the discovery that galectin-1 (Gall) plays a role in viral-associated PTLD, e.g., EBV-associated PTLD and hypoxia associated angiogenesis disorders. Accordingly, the invention relates to compositions, kits, and methods for diagnosing, prognosing, monitoring, treating and modulating viral-associated PTLD, e.g., EBV-associated PTLD and hypoxia associated angiogenesis disorders.</p> |
申请公布号 |
CA2778953(A1) |
申请公布日期 |
2011.05.19 |
申请号 |
CA20102778953 |
申请日期 |
2010.11.12 |
申请人 |
DANA-FARBER CANCER INSTITUTE, INC.;THE BRIGHAM AND WOMEN'S HOSPITAL, INC;CONSEJO NACIONAL DE INVESTIGACIONES CIENTIFICAS YTECNICAS (CONICET);FUNDACION SALES |
发明人 |
|
分类号 |
C07K16/18;A61K39/395;C07K16/46;C12N15/13;G01N33/577 |
主分类号 |
C07K16/18 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|